Optiscan Imaging Ltd has released a press release.
Optiscan Initiates GI Study in Germany with First Prototype
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- OIL December 2024 Quarterly Report and Appendix 4C
- Optiscan receives $1.775m R&D Tax Refund
- OIL Managing Director's Presentation & Chair's Address
- Optiscan Signs Research Agreement with Minnesota Vet College
- Optiscan Signs Agreement with Monash to Progress GI Scope
Later from Optiscan Imaging
- Optiscan Reveals InForm Imaging Device for Pathology
- Robotic Surgery Collaboration with Mayo Clinic Progresses
- Optiscan Completes Cloud-based Telepathology Software MVP
- Optiscan Reveals InSpecta Device for Veterinary Medicine
- Optiscan Signs Agreement with Long Grove Pharmaceuticals
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging